Lin Jiang

3.9k total citations · 1 hit paper
98 papers, 1.9k citations indexed

About

Lin Jiang is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Lin Jiang has authored 98 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Surgery, 32 papers in Cardiology and Cardiovascular Medicine and 28 papers in Molecular Biology. Recurrent topics in Lin Jiang's work include Acute Myocardial Infarction Research (18 papers), Cardiac Imaging and Diagnostics (16 papers) and Coronary Interventions and Diagnostics (15 papers). Lin Jiang is often cited by papers focused on Acute Myocardial Infarction Research (18 papers), Cardiac Imaging and Diagnostics (16 papers) and Coronary Interventions and Diagnostics (15 papers). Lin Jiang collaborates with scholars based in China, United States and United Kingdom. Lin Jiang's co-authors include Yingbin Liu, Yunping Hu, Xiangsong Wu, Yijian Zhang, Yang Cao, Maolan Li, Yuanyuan Ye, Shanshan Xiang, Yi Xiao and Yajuan Hao and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Lin Jiang

90 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comprehensive metabolomics expands precision medicine for triple-negative breast cancer

2022 202 citations Lin Jiang, Yi‐Zhou Jiang et al. profile →

Peers

Lin Jiang

ONCOL

SURGE

PRM

Graham P. Pidgeon Ireland

Naveen Vasudev United Kingdom

Cheng Huang China

Hyun Jo Youn South Korea

Xu Guan China

Luigi Rossi Italy

Dongshan Zhang China

Sung‐Jig Lim South Korea

Graham P. Pidgeon Ireland

Lin Jiang

1.0k ×1.1

656 ×1.0

635 ×1.8

ONCOL

456 ×1.3

SURGE

390 ×1.5

PRM

Citations per year, relative to Lin Jiang Lin Jiang (= 1×) peers Graham P. Pidgeon

Countries citing papers authored by Lin Jiang

Since Specialization

Citations

This map shows the geographic impact of Lin Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Jiang more than expected).

Fields of papers citing papers by Lin Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Jiang. The network helps show where Lin Jiang may publish in the future.

Co-authorship network of co-authors of Lin Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Jiang. A scholar is included among the top collaborators of Lin Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Jiang. Lin Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Mingfeng, Xinghan Wu, Lin Jiang, et al.. (2025). Exploring the co‐morbid relationship between Alzheimer's disease and lung cancer in the 5xFAD transgenic mouse model. Animal Models and Experimental Medicine. 8(5). 784–797.

Wen, Xiang‐mei, Zi‐jun Xu, Ji‐chun Ma, et al.. (2025). Bioinformatic characterization of STING expression in hematological malignancies reveals association with prognosis and anti-tumor immunity. Frontiers in Immunology. 16. 1477100–1477100. 1 indexed citations

Li, Qinxue, Zheng Zhang, Jingjing Xu, et al.. (2024). The combined effect of triglyceride–glucose index and high‐sensitivity C‐reactive protein on cardiovascular outcomes in patients with chronic coronary syndrome: A multicenter cohort study. Journal of Diabetes. 16(8). e13589–e13589. 6 indexed citations

Jiang, Lin, et al.. (2024). Immune Checkpoint Inhibitors-Associated Diabetes and Ketoacidosis Were Found in FDA Adverse Event Reporting System: A Real-World Evidence Database Study. Endocrine Practice. 30(9). 887–892. 1 indexed citations

Jiang, Lin, et al.. (2024). Deformation characteristics and exploration potential of the West Kunlun foreland fold-and-thrust belt. ADVANCES IN GEO-ENERGY RESEARCH. 11(3). 181–193. 3 indexed citations

Zhang, Yu, Ce Zhang, Lin Jiang, et al.. (2023). An elevated triglyceride-glucose index predicts adverse outcomes and interacts with the treatment strategy in patients with three-vessel disease. Cardiovascular Diabetology. 22(1). 333–333. 11 indexed citations

Song, Ying, Zheng Zhang, Jingjing Xu, et al.. (2023). Stress hyperglycemia ratio and long‐term prognosis in patients with acute coronary syndrome: A multicenter, nationwide study. Journal of Diabetes. 15(7). 557–568. 22 indexed citations

Zhang, Yingjing, et al.. (2023). Comparison of the predictive value of pathological response at primary tumor and lymph node status after neoadjuvant chemotherapy in locally advanced gastric cancer. Clinical & Translational Oncology. 25(8). 2462–2471. 5 indexed citations

Zhang, Lingxiao, Lin Jiang, Ling Zeng, et al.. (2023). The oncogenic role of NF1 in gallbladder cancer through regulation of YAP1 stability by direct interaction with YAP1. Journal of Translational Medicine. 21(1). 306–306. 5 indexed citations

10.

Jiang, Lin, Yingjing Zhang, Yu Tian, et al.. (2023). Perioperative chemotherapy versus adjuvant chemotherapy treatment for resectable locally advanced gastric cancer: a retrospective cohort study. European journal of medical research. 28(1). 409–409. 2 indexed citations

11.

Yuan, Deshan, Tianyu Li, Lin Jiang, et al.. (2023). Mild Renal Function Impairment and Long-Term Outcomes in Patients with Three-Vessel Coronary Artery Disease: A Cohort Study. Cardiorenal Medicine. 13(1). 354–362.

12.

Su, Guan-Hua, Lin Jiang, Yi Xiao, et al.. (2022). A Multiomics Signature Highlights Alterations Underlying Homologous Recombination Deficiency in Triple-Negative Breast Cancer. Annals of Surgical Oncology. 29(11). 7165–7175. 6 indexed citations

13.

Yu, Wenya, Xiang Liu, Yipeng Lv, et al.. (2022). Heterogeneous effects of retirement on the biomedical risk factors for cardiovascular and metabolic diseases: New evidence based on the physical examination database in Shanghai, China. SSM - Population Health. 21. 101333–101333. 4 indexed citations

14.

Jiang, Lin, Zhiqiang Ma, Xin Ye, Weiming Kang, & Jianchun Yu. (2021). Clinicopathological factors affecting the effect of neoadjuvant chemotherapy in patients with gastric cancer. World Journal of Surgical Oncology. 19(1). 25 indexed citations

15.

Zhao, Xueyan, Lianjun Xu, Lin Jiang, et al.. (2021). Real-world outcomes of different treatment strategies in patients with diabetes and three-vessel coronary disease: a mean follow-up 6.3 years study from China. Cardiovascular Diabetology. 20(1). 16–16. 6 indexed citations

16.

Wang, Meiniang, Xinhua Zhang, Chuxin Liu, et al.. (2020). The novel llama‐human chimeric antibody has potent effect in lowering LDL‐c levels in hPCSK9 transgenic rats. SHILAP Revista de lepidopterología. 9(1). 16–16. 11 indexed citations

17.

Zhao, Xueyan, Jiawen Li, Xiaofang Tang, et al.. (2020). Association of NPC1L1 and HMGCR Gene Polymorphisms with Major Adverse Cardiac and Cerebrovascular Events in Patients with Three-Vessel Disease. Human Gene Therapy. 32(11-12). 581–588. 5 indexed citations

18.

Wang, Yue, Yang Yu, Wei Han, et al.. (2020). CT Radiomics for Distinction of Human Epidermal Growth Factor Receptor 2 Negative Gastric Cancer. Academic Radiology. 28(3). e86–e92. 24 indexed citations

19.

Feng, Xinxing, Ce Zhang, Lin Jiang, et al.. (2020). Body mass index and mortality in patients with severe coronary artery diseases: A cohort study from China. Nutrition Metabolism and Cardiovascular Diseases. 31(2). 448–454. 8 indexed citations

20.

Jiang, Lin, Lianjun Xu, Jian Tian, et al.. (2019). Impact of Lipoprotein(a) on Long-Term (Mean 6.2 Years) Outcomes in Patients With Three-Vessel Coronary Artery Disease. The American Journal of Cardiology. 125(4). 528–533. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Graham P. Pidgeon Breakdown of academic impact, for papers by Naveen Vasudev Breakdown of academic impact, for papers by Cheng Huang Breakdown of academic impact, for papers by Hyun Jo Youn Breakdown of academic impact, for papers by Xu Guan Breakdown of academic impact, for papers by Luigi Rossi Breakdown of academic impact, for papers by Dongshan Zhang Breakdown of academic impact, for papers by Sung‐Jig Lim